| 000 | 01883 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517054556.0 | ||
| 264 | 0 | _c20170327 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1860-7187 | ||
| 024 | 7 |
_a10.1002/cmdc.201500383 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBenek, Ondrej | |
| 245 | 0 | 0 |
_aDesign, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease. _h[electronic resource] |
| 260 |
_bChemMedChem _c06 2016 |
||
| 300 |
_a1264-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcholinesterase _xchemistry |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xmetabolism |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xchemical synthesis |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xchemistry |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aQuinolines _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTacrine _xchemistry |
| 700 | 1 | _aSoukup, Ondrej | |
| 700 | 1 | _aPasdiorova, Marketa | |
| 700 | 1 | _aHroch, Lukas | |
| 700 | 1 | _aSepsova, Vendula | |
| 700 | 1 | _aJost, Petr | |
| 700 | 1 | _aHrabinova, Martina | |
| 700 | 1 | _aJun, Daniel | |
| 700 | 1 | _aKuca, Kamil | |
| 700 | 1 | _aZala, Dominykas | |
| 700 | 1 | _aRamsay, Rona R | |
| 700 | 1 | _aMarco-Contelles, José | |
| 700 | 1 | _aMusilek, Kamil | |
| 773 | 0 |
_tChemMedChem _gvol. 11 _gno. 12 _gp. 1264-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cmdc.201500383 _zAvailable from publisher's website |
| 999 |
_c25316155 _d25316155 |
||